Skip to main content
Pei-Ling Chen, MD, Pathology, Saint Louis, MO, H. Lee Moffitt Cancer Center and Research Institute

Pei-LingChenMD

Pathology Saint Louis, MO

Dermatopathology, Anatomic Pathology, Clinical Pathology

Physician

Are you Dr. Chen?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

  • Connect with colleagues in the same hospital or clinic
    You already have 21 invites waiting!
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

Claim this profile

Not you? Find your profile

Summary

  • Dr. Pei-Ling Chen, MD is a board certified pathologist in Saint Louis, Missouri. She is currently licensed to practice medicine in Missouri and Florida. She is affiliated with H. Lee Moffitt Cancer Center and Research Institute.

Education & Training

  • Washington University/B-JH/SLCH Consortium
    Washington University/B-JH/SLCH ConsortiumResidency, Pathology-Anatomic and Clinical, 2010 - 2014
  • The Warren Alpert Medical School of Brown University
    The Warren Alpert Medical School of Brown UniversityClass of 2003
  • University of Texas M D Anderson Cancer Center
    University of Texas M D Anderson Cancer CenterFellowship, Dermatopathology

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2017 - 2025
  • MO State Medical License
    MO State Medical License 2016 - 2017
  • American Board of Pathology Pathology - Anatomic
  • American Board of Pathology Dermatopathology

Publications & Presentations

PubMed

Press Mentions

  • Genomic Alterations Identified in Cutaneous T-cell Lymphoma Could Provide Path to New Therapies
    Genomic Alterations Identified in Cutaneous T-cell Lymphoma Could Provide Path to New TherapiesMarch 1st, 2022
  • Key Genomic Alterations and Potential Therapeutic Vulnerabilities Identified in Transformed Cutaneous T-cell Lymphoma
    Key Genomic Alterations and Potential Therapeutic Vulnerabilities Identified in Transformed Cutaneous T-cell LymphomaMarch 1st, 2022

Hospital Affiliations